Introduction
Stenotrophomonas maltophilia is an increasingly frequent cause of infection, particularly in debilitated or immunocompromised patients with central venous catheters, 1, 2 and in intubated patients with respiratory infections. 3 Recent reports also describe cellulitis caused by S. maltophilia in cancer patients. 4, 5 S. maltophilia has been isolated from the sputum of up to 10% of cystic fibrosis patients although its pathogenic significance is uncertain. 6, 7 S. maltophilia produces an inducible zinc-metalloenzyme with carbapenemase activity (L1 enzyme) conferring resistance to imipenem. 8 We have investigated the differences in the results of susceptibility testing of S. maltophilia derived from use of meropenem rather than imipenem.
Materials and methods

Bacterial strains
The test strains were 20 unrelated significant clinical isolates of S. maltophilia from Bristol PHL at Bristol Royal Infirmary (1993-5), comprising 19 blood culture isolates (strains B-T) and one isolate from a sputum sample (strain A). Isolates were identified using the API 20 NE System (API, 69280 Marcy-l'Etoile, France).
Sensitivity tests
Disc sensitivity tests were performed on Iso-Sensitest agar (Oxoid plc, Basingstoke, UK) with imipenem 10 g and meropenem 10 g discs (Oxoid). Plates were incubated for 18 h at 37°C in 5% CO 2 prior to reading.
MICs were determined by the agar dilution method 9 with imipenem (MSD, Hoddesdon, UK), and meropenem (Zeneca, Wilmslow, UK). Tests were performed in duplicate with an inoculum of approximately 10 4 cfu per spot over an antibiotic range of 1-128 mg/L. Initial MICs were determined after incubation in air at 37°C, air at 30°C and 5% CO 2 at 37°C for 18 h. The MICs of test strains and resistance mutants were determined after incubation in 5% CO 2 at 37°C for 18 h.
Selection of resistant mutants
Meropenem-resistant mutants were selected by inoculating plates to give confluent growth and incubating with a 10 g meropenem disc. After overnight incubation the disc was removed and the plate incubated for a further 24 h. Colonies growing within the original zone of inhibition ( Figure 1) were picked and MICs were tested following repeated subculture on to a non-selective medium. 
13
Susceptibility testing of
Tests for induction of L1 carbapenemase
Qualitative tests for induction of carbapenemase activity were performed using a disc approximation method.
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Induction and preparation of -lactamases
Bacterial strains were grown overnight in LabM Nutrient broth no. 2 (Amersham, Bury, UK) at 37°C. A 1:20 dilution of each culture was made into 50 mL fresh LabM Nutrient broth no. 2 and shaken at 37°C until mid-log phase (OD 420 0.8) had been reached. For -lactamase induction, the inducer was added at a concentration of 0.25 MIC to the mid-log phase culture in 50 mL fresh, prewarmed LabM medium and shaken for 1 h. Control cultures were diluted with medium lacking inducer. Uninduced and induced cultures were harvested by centrifugation at 4°C. The cells were washed twice in ice-cold 10 mM phosphate buffer (pH 7.0), resuspended in 10 mL 10 mM phosphate buffer and disrupted by sonication (Ultrasonic disintegrator, four 15 s bursts with 15 s cooling periods, amplitude 1; MSE Scientific Instruments, Crawley, Sussex, UK).
-Lactamase assays
Hydrolysis of -lactam antibiotics was examined by UV spectrophotometric assays (Pharmacia LKB Ultrospec II) in 1 cm light-path cuvettes with readings recorded at 10 s intervals for 5 min at a wavelength of optimal absorbance for the -lactam ring of each drug, i.e. 299 nm for meropenem and imipenem. Antibiotic solutions were prepared in 10 mM phosphate buffer, pH 7.0. For substrate profiles, each antibiotic was assayed at a concentration of 100 M. One unit oflactamase is defined as the amount of enzyme required to hydrolyse 1 nmol of substrate per min per mg of protein, in the linear phase of the reaction at 37°C.
Results
Disc sensitivity
The sputum isolates (strain A) from a patient known to be colonized with a biochemically confirmed strain of S. maltophilia gave a large zone of inhibition to meropenem but grew up to an imipenem disc (Figure 2 ) when incubated for 18 h in 5% CO 2 . The 19 other strains tested all gave large zones of inhibition to meropenem but grew up to imipenem discs.
MIC determinations
The MICs for the 20 test strains are shown in Table I . There was a clear difference between the MICs of meropenem and imipenem. This disparity was maximal when sensitivity was performed at 37°C in 5% CO 2 when the MIC of imipenem was 64 MIC of meropenem.
Carbapenemase induction
Qualitative tests of induction of carbapenemase activity showed variation between strains. Fourteen strains showed some blunting of the meropenem zone and six strains showed marked blunting of the zone (Figure 3) .
Results for L1 enzyme activity and induction experiments are shown in Table II . Basal L1 enzyme activity of the wild strains was at the limit of detection in this system and ranged from 25 to 75 nmol imipenem hydrolysed/ min/mg protein for all strains except for strain R, for which the activity was 150 nmol imipenem hydrolysed/min/mg protein. All strains were tested for L1 enzyme induction by meropenem and those strains which exhibited marked blunting of meropenem zones on qualitative tests were tested for L1 enzyme induction by imipenem. Both imipenem and meropenem induced increased L1 activity.
Selection of resistant mutants
Mutants resistant to meropenem were very readily selected. Nine of our 20 strains gave resistant mutants at the first attempt. These mutants were stably resistant to meropenem following repeated subculture on blood agar. The MICs for resistant mutants are given in Table III. Carbapenemase activity and induction by meropenem of the resistant strains are shown in Table II . Resistant mutants tended to display higher basal carbapenemase activity than the wild strains and still retained the potential for induction by meropenem. These resistant mutants were therefore partially stably derepressed.
Discussion
We are not aware of any previous reports describing discrepant results for different testing methods for the susceptibility of S. maltophilia to meropenem and imipenem.
The major contribution to the resistance of S. mal - tophilia to carbapenem is from production of the inducible L1 carbapenemase. 10 The cause of the decreased MICs of meropenem for S. maltophilia is unknown but may involve reduced induction of the L1 carbapenemase. Our induction experiments show that both meropenem and imipenem induce the L1 enzyme. However, the qualitative tests of enzyme induction suggest that imipenem is capable of inducing resistance to meropenem, presumably by increased induction of the L1 enzyme.
Akova et al. 10 reported that mutant strains of S. maltophilia with basal expression of the L1 enzyme were eight to 16 times more sensitive to meropenem than imipenem. This suggests that alternative mechanisms of resistance, such as increased membrane permeability to meropenem and possibly differences in target affinity, may contribute to the observed lower MICs of meropenem. Altered outer membrane permeability has been associated with resistance to quinolones 11 and temperature-dependent gentamicin resistance 12, 13 in S. maltophilia. Differences in target affinity between meropenem and imipenem have been reported in Pseudomonas aeruginosa. Meropenem is reported to have greater activity than imipenem and it is suggested that this is because the primary target for imipenem is penicillin-binding protein 2 (PBP2) while meropenem has high affinity for both PBP2 and PBP3. 14 Many workers have reported the variability in susceptibility results for S. maltophilia according to medium 10, 15, 16 or incubation temperature. 17 Our results showed a decreased MIC of carbapenems when S. maltophilia was Imipenem treatment has been suggested as a risk factor for infection/colonization with S. maltophilia. 18, 19 It is possible in view of our results, that meropenem treatment of patients would be less likely to select for colonization by S. maltophilia. Laboratories should be aware that many strains of S. maltophilia may give large zones of inhibition to meropenem and, therefore if carbapenem resistance is to be used to alert laboratory staff to the presence of S. maltophilia then imipenem discs should be used. In addition, it should be noted that standard sensitivity tests with meropenem may be poorly predictive of the clinical outcome of treatment of S. maltophilia infections with meropenem.
